Welcome to our dedicated page for Afya SEC filings (Ticker: AFYA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Afya's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Afya's regulatory disclosures and financial reporting.
Afya Ltd director Christina Bacon Krebs filed an initial statement of beneficial ownership on Form 3. This filing establishes her status as a reporting insider of the company. It does not list any transactions or changes in ownership, only her entry into insider reporting obligations.
Afya Ltd vice president Stella Caldeira Brant Rodrigues filed an initial ownership report showing her equity position in the company. She directly holds 39,140 Class A Common Shares as of the filing date.
She also holds stock options covering 80,000 Class A Common Shares, with exercise prices of R$62.59 and R$52.00 and expiration dates from May 1, 2027 through May 1, 2030; these options fully vest and become exercisable three years before each expiration date, subject to continued service, and the exercise prices are denominated in Brazilian reais.
In addition, she has restricted stock units over 17,600 Class A Common Shares with no expiration date that will vest on May 1, 2026, also subject to her continued service through that vesting date.
Afya Ltd director Esteves Nicolau Carvalho filed an initial ownership report showing existing stakes in the company, with no new buy or sell transactions. The filing lists indirect holdings through NRE Capital Ventures Ltd., including Class B Common Shares that are convertible into Class A Common Shares on a one-for-one basis with no expiration date.
Afya Ltd director Renato Tavares Esteves filed an initial ownership report showing indirect beneficial ownership of 1,263,613 Class A common shares. These shares are held through RTE B Ventures Ltd., which is solely owned and controlled by Esteves.
Afya Ltd’s Chief Financial Officer, Luis Andre Carpintero Blanco, has filed an initial Form 3 detailing his equity holdings. He directly holds 61,103 Class A Common Shares. He also holds stock options to buy 14,000 Class A shares in each of five grants at an exercise price of 62.5900, expiring between May 2029 and May 2033, and options on 23,500 shares in each of two grants at an exercise price of 52.0000, expiring in May 2029 and May 2030.
In addition, he holds restricted stock units covering 35,000, 3,200 and 16,800 Class A shares. According to the footnotes, these RSUs vest on May 1 of 2026, 2027, 2028 and 2029, subject to his continued service with the company.
Afya Ltd director Krafft Kay Christian filed an initial insider ownership report on Form 3. This filing establishes his status as a director and discloses that, in this report, there are no insider share purchases, sales, option exercises, gifts, or other transactions recorded.
Afya Ltd filed an initial insider ownership report for director Pereira de Paula Miguel Filisbino. This Form 3 does not report any purchases, sales, gifts, or other transactions, and it shows no derivative positions or other holdings in the sections visible in this data.
Afya Ltd director Vanessa Claro Lopes filed an initial Form 3 reporting her beneficial ownership in the company. The filing shows she directly holds 1,315 Class A common shares following the reported position. This is a registration of existing holdings rather than a new buy or sell transaction.
Afya Ltd filed a Form 3 identifying Dominik Dalkmann Benedikt Karl as a director and reporting person. The insider filing data show no reported share transactions or derivative positions, indicating this is an initial ownership statement rather than a report of buys or sells.
Afya Limited files a Form 144 notice reporting a proposed sale of 150,000 Class A common shares with an aggregate value of $2,064,000.00, listed for sale through Itau International Securities Inc on 03/17/2026 on Nasdaq Global Select.
The filing also lists recent acquisitions that affect available holdings: 17,953 shares from a Restricted Share Units Program (05/01/2023), 38,027 shares from RSUs (05/01/2025), and 100,000 shares issued under a Stock Option Plan (S-8) (06/27/2025), plus an entry showing $2,064,000.00 aggregate and a separate date 06/09/2025 tied to a cash-related line item.